ANTONIO HEROLD: Open Payments
NPI 1588286520 · HAVRE DE GRACE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,753 in 124 payments from 15 companies in 2025. Trend: 2023 $1,519 · 2024 $2,141 · 2025 $17,753
Speaker / faculty: $14,875Food & beverage: $2,374Travel & lodging: $504
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 65 | $16,015 |
| Supernus Pharmaceuticals, Inc. | 8 | $253 |
| Vanda Pharmaceuticals Inc. | 8 | $245 |
| Janssen Pharmaceuticals, Inc | 6 | $242 |
| Axsome Therapeutics, Inc. | 8 | $232 |
| Otsuka America Pharmaceutical, Inc. | 3 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $129 |
| E.R. Squibb & Sons, L.L.C. | 4 | $101 |
| Lundbeck LLC | 5 | $99 |
| Sage Therapeutics, LLC | 3 | $87 |
Products named: VRAYLAR, Qelbree, SPRAVATO, REXULTI, Auvelity, HETLIOZ, CAPLYTA, COBENFY.
Industry payments across MD — which companies pay providers there.
